|
RE104 for Injection Clinical Trials
2 actively recruiting trials across 1 location
No change since August 2026
Pipeline
Phase 2: 2
Top Sponsors
- Reunion Neuroscience Inc2
Indications
- Anxiety2
- Generalized Anxiety Disorder1
- Adjustment Disorder1
- Depression1
- Multiple Sclerosis1
Birmingham, Alabama2 trials
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
UAB, Psychiatry and Behavioral Neurology
Phase 2
RE104 Safety and Efficacy Study in Generalized Anxiety Disorder
University of Alabama (UAB) Clinical Research Unit (CRU)
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.